In Alzheimer's disease mouse model, HT chronic treatment (10 mg/day by gavage for 14 days) attenuated the spatio-cognitive deficits and normalized the hippocampal BDNF mRNA levels [91]. Here, BDNF is linked to Alzheimer disease.